2010
DOI: 10.1111/j.1529-8019.2010.01373.x
|View full text |Cite
|
Sign up to set email alerts
|

THERAPEUTIC HOTLINE: Successful treatment of Morbihan's disease with oral prednisolone and doxycycline

Abstract: Persistent facial swelling can occur as a rare complication of rosacea. This finding is referred to as lymphedematous rosacea or Morbihan's disease. We report a case of a 45-year-old male with no previous history of rosacea who developed bilateral periorbital swelling associated with facial erythema and edema that responded to a combination of oral corticosteroids and doxycycline. Biopsy revealed changes of granulomatous rosacea.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0
4

Year Published

2011
2011
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(28 citation statements)
references
References 14 publications
1
21
0
4
Order By: Relevance
“…In one case, the combination of prednisolone of 20 mg/day for 2 weeks and doxycycline of 200 mg/day for 12 weeks improved the oedema and erythema (11). In contrast, minocycline monotherapy for 6 to 7 months did not show apparent improvement (dosage not avail able) (8).…”
Section: Successful Treatment Of Morbihan Disease With Long-term Minomentioning
confidence: 89%
“…In one case, the combination of prednisolone of 20 mg/day for 2 weeks and doxycycline of 200 mg/day for 12 weeks improved the oedema and erythema (11). In contrast, minocycline monotherapy for 6 to 7 months did not show apparent improvement (dosage not avail able) (8).…”
Section: Successful Treatment Of Morbihan Disease With Long-term Minomentioning
confidence: 89%
“…Generally, little to no improvement in facial edema is noted with the use of pharmacological agents, leading many clinicians to pursue more invasive, yet also unreliable, treatments such as blepharoplasty, carbon dioxide laser, and local injections. 6,10,11,13,20,21 There are fewer than a handful of publications documenting the use of oral isotretinoin for the treatment of MD, which was first described by Jansen and Plewig 22 in 1997; however, all publications report its use in combination with oral corticosteroids or antihistamines, and treatment duration has varied from 6 to 16 weeks, with daily dosing between 10 and 50 mg. 5,10,22 Also, these treatment regimens were marked by incomplete or transient improvements in clinical findings 6,10,22,23 ; yet the notable improvement in both facial erythema and edema was indicative of oral isotretinoin as a promising therapeutic option compared with other pharmacological agents. It is possible that the conservative dosing and brief treatment duration documented in these reports contributed to the partial success of isotretinoin therapy for MD.…”
Section: Treatmentmentioning
confidence: 99%
“…11,13 These agents have been used alone or in combination. At best, they are associated with a reduction of facial erythema; however, more often than not, the clinical response is partial and short-lived.…”
Section: Treatmentmentioning
confidence: 99%
See 2 more Smart Citations